Firelli Alonso, Ph.D., Pfizer, Inc. - Qepler Summits And Conferences

Firelli Alonso, Ph.D.

Senior Director, External Supply BioTherapeutics Pharmaceutical Sciences
Pfizer, Inc.
New York, USA
Pfizer: One of the world's premier biopharmaceutical companies

Dr. Firelli Alonso is Senior Director, External Supply at Pfizer, Inc. She heads the BioTherapeutics and Vaccines Outsourcing group in Worldwide Research and Development. Fi has 34 years of combined experience in research, development, and cGMP production of biological products and vaccines, and 14 years of experience in outsourcing, project / contract management, and technology transfer to qualified third parties. Her areas of expertise include viral vectors and viral vaccine development, recombinant proteins, vaccine process development and cGMP production, project management, technology transfer, outsourcing, and budgets and operations.

She obtained her Ph.D. in Microbiology from the University of Alabama in Birmingham, followed by postdoctoral research at the U.S. Army Medical Research Institute for Infectious Diseases, Sloan-Kettering Institute for Cancer Research, and Rutgers University, Center for Advanced Biotechnology and Medicine. Prior to joining Wyeth / Pfizer in 1996, Fi worked at The Salk Institute (Government Services Division), a vaccine contract manufacturer for the U.S. Armed Forces.

Related Sessions:

Highly Potent APIs
Summit 2019

Assess and reduce manufacturing and handling challenges for highly potent active pharmaceutical ingredients.
  • 20 Feb 2019
  • Berlin, DE
  • Pharma
Day 2: Thursday, 21 February 2019
CASE STUDY: Challenges and Successes in Externalization of the ADC Supply Chain.
  • Strategizing the best outsourcing practices for producing and testing ADCs for use in clinical trials
  • Establishing guiding principles for externalization to ensure the selection of the right CMOs for ADC outsourcing and technology transfer
  • Gaining insights into the complex technology transfer process for ADC manufacture and analytical control
  • Sizing appropriately of ADC support network to expedite transition from clinical to commercial manufacturing
View Details